Andrew M. Stein

2.0k citations

39 papers · 1.3k indexed · h-index 19

Impact in

Modeling and Simulation top 2%
- Mathematical Biology Tumor Growth
Aging top 5%

Papers in

Aging 2
Modeling and Simulation 3

Co-authors: Leonard M. Sander David Vader David A. Weitz Michael E. Berens Tim Demuth David L. Mobley Louise Jawerth F E Speizer
Journals: Journal of Clinical Oncology (4 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Blood (4 papers)Journal of Pharmacokinetics and Pharmacodynamics (3 papers)BMC Cancer (2 papers)
Partner nations: United States Switzerland China

In The Last Decade

Andrew M. Stein

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by Andrew M. Stein

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Stein more than expected).

Fields of papers citing papers by Andrew M. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Stein. The network helps show where Andrew M. Stein may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew M. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew M. Stein Line = papers co-authored together Andrew M. Stein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sabatolimab (MBG453) model‐informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors CPT Pharmacometrics & Systems Pharmacology ·Siyan Xu, Lucia Raluca Ardelean, Mikael L. Rinne, Haiying Sun, Andrew M. Stein	2023	11
2	Mechanistically Weighted Metric to Predict In Vivo Antibody-Receptor Occupancy: An Analytical Approach Journal of Pharmacology and Experimental Therapeutics ·Eshita Khera, Jaeyeon Kim, Andrew M. Stein, Ben S. Ross, Greg M. Thurber	2023	0
3	Current practices for QSP model assessment: an IQ consortium survey Journal of Pharmacokinetics and Pharmacodynamics ·Jason R. Chan, Richard Allen, Britton Boras, Antonio Cabal, Valeriu Damian, Francis D. Gibbons, Abhishek Gulati, Iraj Hosseini, Jeffrey D. Kearns, Amit Kumar Semil, L. Cucurull-Sanchez, Jangir Selimkhanov, Andrew M. Stein, Kenichi Umehara, 국홍일, A C Fabian, Susana R. Neves	2022	16
4	Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy Blood ·Boris Engels, マリ森嶋, 藤治宮崎, Andrew Price, J Pennock Michael, Andrew M. Stein, Lana Parent, Michael Greene, Matthew J. Niederst, Annie Vincent, Elena J. Orlando, Anna-Lena Mädge, Jennifer L. Brogdon	2021	19
5	Estimating drug potency in the competitive target mediated drug disposition (TMDD) system when the endogenous ligand is included. Journal of Pharmacokinetics and Pharmacodynamics ·emel yüksel, Thakar Hetal Ghanashyambhai, Magdalena Campion, Vishruti Makani, Andrew M. Stein	2021	4
6	Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review Annals of Surgical Oncology ·Andrew M. Stein, ايمن احمد انسي الاسكندراني, T. Clark Gamblin, Callisia N. Clarke, Susan Tsai, James P. Thomas, Ben George, Harveshp Mogal	2019	21
7	Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells CPT Pharmacometrics & Systems Pharmacology ·Andrew M. Stein, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Bruce L. Levine, LUXiao, Sweta Shah, Mimi Leung, Salim Nurul F., Rakesh Awasthi, Karen Thudium Mueller, Patricia A. Wood, Carl H. June	2019	102
8	Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems Journal of Pharmacokinetics and Pharmacodynamics ·Dino Saputra, 兰三, Hongshan Li, Ann Trabue Bass, Andrew M. Stein	2019	10
9	CTL019 Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor (CAR) T Cells to Characterize the Impact of Tocilizumab on Expansion and to Identify Correlates of Cytokine Release Syndrome Severity Blood ·Andrew M. Stein, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Bruce L. Levine, Carl H. June, LUXiao, Sweta Shah, Mimi Leung, Salim Nurul F., Sara Mahmoud Othman, Rakesh Awasthi, Karen Thudium Mueller, Patricia A. Wood, Shannon L. Maude	2017	3
10	Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Varun Goel, Eunju Hurh, Andrew M. Stein, Jerry Nedelman, Anna Strimaitis Grinath, Binsyah Sari Indah Gajah Manik, Salim Nurul F., Sven Gogov, Dalila Sellami	2016	33
11	Neuropeptides Amplify and Focus the Monoaminergic Inhibition of Nociception in Caenorhabditis elegans Journal of Neuroscience ·Vera Hapiak, Philip Summers, 美雄八木, Wen Jing Law, Andrew M. Stein, Richard Komuniecki	2013	33
12	BCR–ABL Transcript Dynamics Support the Hypothesis That Leukemic Stem Cells Are Reduced during Imatinib Treatment Clinical Cancer Research ·Andrew M. Stein, Dean Bottino, Vijay Modur, Susan Branford, Jaspal Kaeda, John M. Goldman, Timothy P. Hughes, Jerald P. Radich, Andreas Hochhaus	2011	32
13	Dissecting the Serotonergic Food Signal Stimulating Sensory-Mediated Aversive Behavior in C. elegans PLoS ONE ·Gareth Harris, Yuanfang Wang, Philip Summers, Vera Hapiak, Wen Jing Law, Andrew M. Stein, Patricia R. Komuniecki, Richard Komuniecki	2011	44
14	The micromechanics of three‐dimensional collagen‐I gels Complexity ·Andrew M. Stein, David Vader, David A. Weitz, Leonard M. Sander	2010	125
15	Inference of imatinib (IM) effects on leukemic stem cell (SC) compartment via mathematical modeling of IRIS treatment response data Journal of Clinical Oncology ·Dean Bottino, Ute Volbehr, Andrew M. Stein, Ani Georgieva, Jifeng Yu, Joseph Kahn, Gabriel Helmlinger, Thea Kalebic	2009	2
16	Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3 Neuro-Oncology ·Michal O. Nowicki, Nina Dmitrieva, Andrew M. Stein, Jennifer L. Cutter, Jakub Godlewski, Yoshinaga Saeki, Shiao-Min Tseng, Michael E. Berens, Leonard M. Sander, Herbert B. Newton, E. Antonio Chiocca, Sean Lawler	2008	100
17	An algorithm for extracting the network geometry of three‐dimensional collagen gels Journal of Microscopy ·Andrew M. Stein, David Vader, Louise Jawerth, David A. Weitz, Leonard M. Sander	2008	155
18	Estimating the cell density and invasive radius of three-dimensional glioblastoma tumor spheroids grown in vitro Applied Optics ·Andrew M. Stein, Michal O. Nowicki, Tim Demuth, Michael E. Berens, Sean Lawler, E. Antonio Chiocca, Leonard M. Sander	2007	9
19	A model for glioma growth This paper was submitted as an invited paper resulting from “Understanding Complex Systems” conference held at University of Illinois-Urbana Champaign, May 2005 La Medicina del lavoro ·Evgeniy Khain, Leonard M. Sander, Andrew M. Stein	2005	1
20	The relationship of blood lead to systolic blood pressure in a longitudinal study of policemen. Environmental Health Perspectives ·Scott T. Weiss, Álvaro Muñoz, Andrew M. Stein, David Sparrow, F E Speizer	1988	17

About Andrew M. Stein

Andrew M. Stein is a scholar working on Aging, Modeling and Simulation, Genetics, Hematology and Statistics and Probability, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (5 papers), CAR-T cell therapy research (5 papers), Computational Drug Discovery Methods (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cellular Mechanics and Interactions (4 papers), Renal cell carcinoma treatment (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Modeling and Simulation (169 citations), Aging (64 citations), Cell Biology (311 citations), Oncology (379 citations) and Genetics (111 citations). Andrew M. Stein has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Leonard M. Sander, David Vader, David A. Weitz, Michael E. Berens, Tim Demuth, David L. Mobley, Louise Jawerth, F E Speizer, Scott T. Weiss and David Sparrow. Their work appears in journals such as Journal of Clinical Oncology, CPT Pharmacometrics & Systems Pharmacology, Blood, Journal of Pharmacokinetics and Pharmacodynamics and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact